Fibrocell and RDEB
9 mar 2018 ·
27 min. 49 sec.
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Jeanine Cook-Gerard from the Department of Nursing talks with John Maslowski, President and Chief Executive Officer of Fibrocell, about the rare genetic skin disease Recessive Dystrophic Epidermolysis Bullosa (RDEB). John...
mostra di più
Jeanine Cook-Gerard from the Department of Nursing talks with John Maslowski, President and Chief Executive Officer of Fibrocell, about the rare genetic skin disease Recessive Dystrophic Epidermolysis Bullosa (RDEB). John describes Fibrocell’s main objective - to find a cure for RDEB and announces that the FDA is now allowing the second phase of this clinical trial in which Fibrocell will be enrolling six pediatric patients ages 7 and older.
mostra meno
Informazioni
| Autore | 90.3 WHPC |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
